System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Hnin Aung is an expert in Pulmonology at University of Leicester (United Kingdom). Hnin Aung has authored 74 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 219 (community average: 125). How the SLR is computed.

LeadR Profile

Hnin Aung University of Leicester United Kingdom
219 ScienceLeadR Reputation 219

Unlock

Register Login
Network Map

Pulmonology

Subspecialties: Public Health - Immunology - Critical Care

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2008 - 2026
Source: PubMed

University of Leicester

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 74

Citations

Citations: 4 480 1st author: 17 Last author: 2 Unique author: 0

Main journals

Lancet 7
Pathology 5
Am J Respir Crit Care Med 3
EClinicalMedicine 2
ERJ Open Res 2

Best Journals

Lancet 7

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Eosinophil-derived breath biomarkers and response to anti-IL-5/5R biologics in severe asthma.
PMID 42421225 — interleukin-5, eosinophils, critical care, biomarkers, asthma		Am J Respir Crit Care Med20261
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
PMID 41581494 — lung, biomedical research, biomarkers, covid-19, matrix metalloproteinases, pulmonary surfactant-associated protein d, infections		EBioMedicine20260
Advancing diagnostic targeted RNA sequencing for haematological malignancies within an Australian sample exchange program.
PMID 41402159 — genes, laboratories, pathology, gene fusion, rna		Pathology20250
Multidimensional prognostic risk stratification of COPD exacerbations: the baseline, acuity, and trigger (BAt) model.
PMID 41314222 — pulmonary disease, chronic obstructive, therapeutics		Lancet Respir Med Top journal20250
Impact of pulmonary rehabilitation programme design on effectiveness in COPD: a systematic review and component network meta-analysis.
PMID 40896469 — exercise, quality of life, rehabilitation, pulmonary disease, chronic obstructive, network meta-analysis, dyspnea		EClinicalMedicine20250

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1
Phase 2/Phase 3 1
Phase 3 1

By status:

Completed 1
Not yet recruiting 1
Recruiting 1

By type:

Interventional 2
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Role of Inhaler Adherence and Blood Eosinophil Count in Exacerbations of COPD
NCT05814484 — chronic disease, lung, blood, cohort studies, eosinophils, pulmonary disease, chronic obstructive, therapeutics, lung diseases, lung diseases, obstructive		N/ANot yet recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS